Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Reck

Showing results (21-30 of 437) with videos related to

Pageof 44
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2020
Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?Jessica Menis, Martin Reck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2017
Response to Letter to the EditorXin Huang, Martin Reck
Respiratory Medicine|March 1, 2005
Gefitinib ("Iressa"): a new therapy for advanced non-small-cell lung cancerMartin Reck, Ulrich Gatzemeier
Deutsche Medizinische Wochenschrift (1946)|April 4, 2018
[CT-Screening for Lung Cancer - what is the Evidence?]Iris Watermann, Martin Reck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2018
Breaking the Glass Ceiling of Overall Survival in Non-Small-Cell Lung CancerNiels Reinmuth, Martin Reck
Progress in Tumor Research|September 19, 2015
Combinations TherapiesNiels Reinmuth, Martin Reck
Expert Review of Anticancer Therapy|September 10, 2014
Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancerDavid Heigener, Martin Reck
Pneumologie (Stuttgart, Germany)|April 24, 2023
[TTF-1-negative lung adenocarcinoma: special features of systemic treatment]Nikolaj Frost, Martin Reck
Seminars in Oncology|May 13, 2015
Immunologic checkpoint blockade in lung cancerMartin Reck, Luis Paz-Ares
Nature Reviews. Clinical Oncology|November 22, 2017
Lung cancer in 2017: Giant steps and stumbling blocksDavid F Heigener, Martin Reck
Pageof 44

Showing results (21-30 of 437) with videos related to

Sort By:
Pageof 44
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2020
Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?Jessica Menis, Martin Reck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2017
Response to Letter to the EditorXin Huang, Martin Reck
Respiratory Medicine|March 1, 2005
Gefitinib ("Iressa"): a new therapy for advanced non-small-cell lung cancerMartin Reck, Ulrich Gatzemeier
Deutsche Medizinische Wochenschrift (1946)|April 4, 2018
[CT-Screening for Lung Cancer - what is the Evidence?]Iris Watermann, Martin Reck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2018
Breaking the Glass Ceiling of Overall Survival in Non-Small-Cell Lung CancerNiels Reinmuth, Martin Reck
Progress in Tumor Research|September 19, 2015
Combinations TherapiesNiels Reinmuth, Martin Reck
Expert Review of Anticancer Therapy|September 10, 2014
Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancerDavid Heigener, Martin Reck
Pneumologie (Stuttgart, Germany)|April 24, 2023
[TTF-1-negative lung adenocarcinoma: special features of systemic treatment]Nikolaj Frost, Martin Reck
Seminars in Oncology|May 13, 2015
Immunologic checkpoint blockade in lung cancerMartin Reck, Luis Paz-Ares
Nature Reviews. Clinical Oncology|November 22, 2017
Lung cancer in 2017: Giant steps and stumbling blocksDavid F Heigener, Martin Reck
Pageof 44